Resumen

HERNANDEZ-ZENTENO, Rafael de Jesús et al. Symptomatic and Asymptomatic Smokers without Airflow Obstruction: A New Clinical Entity?. Rev. invest. clín. [online]. 2019, vol.71, n.1, pp.64-69.  Epub 12-Abr-2021. ISSN 2564-8896.  https://doi.org/10.24875/ric.18002648.

Non-obstructed ever-smokers, with or without symptoms, have generated a great deal of information recently, but few reviews. Even individuals with normal spirometry can present changes in sputum with inflammatory biomarkers (cellular and molecular) and airways and parenchyma with remodeling; when symptomatic (cough, sputum, wheezing, and dyspnea) exacerbations are frequent affecting the individuals’ quality of life, there is an increased use of health resources: more medication, emergency visits, and hospital admissions. Non-obstructed smokers may have exercise limitations, increased lung volumes, low diffusion capacity, air entrapment, peripheral airways obstruction, elevated airways resistance, and abnormal multiple breath nitrogen washout, as well as abnormalities in computed tomography studies, such as airway wall thickening, emphysema, or interstitial lung abnormalities. Quitting smoking comprises a first, inexpensive, and often abandoned intervention to arrest respiratory impairment. It is controversial whether or not this population should be treated with other medications. Further studies should be conducted to elucidate the consequences of follow-up and prognosis in this clinical entity.

Palabras llave : Normal smokers; Healthy smokers; Non-obstructed smokers; Symptomatic smokers; Global initiative for chronic obstructive lung disease 0.

        · texto en Inglés     · Inglés ( pdf )